Loading company…
Riskpilot
← Back to search
Sign in
Get full access
RENEWENCE AS
AS
Active
Org 933023087
Hegdehaugsveien 10, 0167 Oslo
Retail sale of other food · NACE 4727
Est. 2024
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 8,3M
+660% vs 2024
EBITDA margin
-36.3%
-1013% vs 2024
Equity ratio
-143.5%
Financial strength
Net profit 2025
NOK -3,6M
-998% vs 2024
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2024
-3M
-300%
2025
Key figures
Annual report 2025
Revenue
NOK 8,3M
+660%
EBITDA
NOK -3M
-1013%
Net profit
NOK -3,6M
-998%
Total assets
NOK 2,3M
+102%
Equity
NOK -3,4M
-1555%
Employees
0
—
Company information
Legal name
RENEWENCE AS
Org number
933023087
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
16. februar 2024
Share capital
NOK 31 376
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Tre styremedlemmer i fellesskap.
Company purpose
Utvikling og salg av helsekostprodukter og naturlegemidler, samt alt som hører naturlig til dette, herunder å delta i andre selskaper.
Contact
Address
Hegdehaugsveien 10, 0167 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of other food
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
2M
5M
7M
9M
1M
2024
8M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
-3M
2025
Income statement
NOK thousands
Item
2024
2025
Revenue
1 086
8 256
Staff expenses
−4
−441
EBITDA
−269
−2 998
Depreciation & amort.
−8
−13
EBIT
−277
−3 011
Net financials
−50
−579
Profit before tax
−327
−3 590
Tax
−0
−0
Net profit
−327
−3 590
Balance sheet
NOK thousands
Item
2024
2025
Total assets
1 161
2 341
Equity
231
−3 359
Long-term debt
0
0
Short-term debt
930
5 701
Total debt
930
5 701
Financial ratios
5-year trend
EBITDA margin
-36.3%
This company
15.8%
Market median
-330% vs market
2024
2025
Equity ratio
-143.5%
This company
38.2%
Market median
-476% vs market
2024
2025
Return on equity
-359018000.0%
This company
18.4%
Market median
-1951184883% vs market
2024
2025
Net profit margin
-43.5%
This company
8.1%
Market median
-637% vs market
2024
2025
Asset turnover
3.53×
This company
1.12×
Market median
+215% vs market
2024
2025
Debt / equity
1.70×
This company
0.62×
Market median
-174% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-10 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
FF
Fredric Finzi Gjertsen
Chairman
2024
—
—
PO
Patric Okyere Melhus
Chairman
2025
—
—
KA
Kevin Andre Okyere Melhus
Board of Directors
2024
—
—
EH
Elizabeth Huanca Vold
Board of Directors
2024
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Uppercut Holding As
Company
47.0%
47.0%
2024
Fasilitetsmegleren As
Company
46.9%
46.9%
2024
Meller As
Company
2.6%
2.6%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Uppercut Holding As
RENEWENCE AS
(this company)
Board network connections
Board members of RENEWENCE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Fredric Finzi Gjertsen
Chairman
0 companies
Patric Okyere Melhus
Chairman
0 companies
Kevin Andre Okyere Melhus
Board of Directors
0 companies
Elizabeth Huanca Vold
Board of Directors
0 companies